The importance of facial expression and the management of facial nerve injury

Neurosurgery Quarterly

Volumn 14, Issue 4, 2004, Pages 239-248

  Stuart, R Morgan ^a   Byrne, Patrick J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Facial expression; Facial reanimation; Nerve reconstruction

Indexed keywords

ACOUSTIC NEURINOMA; ELECTROMYOGRAPHY; FACE ASYMMETRY; FACIAL EXPRESSION; FACIAL NERVE; FACIAL NERVE INJURY; HUMAN; HYPOGLOSSAL NERVE; INTERPERSONAL COMMUNICATION; MUSCLE TRAINING; MUSCLE TRANSPLANTATION; NERVE GRAFT; NERVE RECONSTRUCTION; NEUROSURGERY; PHYSICAL ATTRACTIVENESS; PHYSIOTHERAPY; PRIORITY JOURNAL; REVIEW; SOCIAL INTERACTION; SURGICAL TECHNIQUE; SYNKINESIS;

EID: 10044225919     PISSN: 10506438     EISSN: None     Source Type: Journal    
DOI: 10.1097/00013414-200412000-00009     Document Type: Review

References (103)

1. Faigin G. The Artist's Complete Guide to Facial Expression. New York: Watson-Guptill Publications; 1990.
2. Schmidt KL, Cohn JF. Human facial expressions as adaptations: evolutionary questions in facial expression research. Yearb Phys Anthropol. 2001;44:3-24.
3. Fridlund A. Human Facial Expression: An Evolutionary View. New York: Academic Press; 1994.
4. Erickson K, Schulkin J. Facial expressions of emotion: a cognitive neuroscience perspective. Brain Cogn. 2003;52:52-60.
5. Bergamasco NH, Beraldo KE. Facial expressions of neonates in response to gustatory stimuli. Braz J Med Biol Res. 1990;23:245-249.
6. Steiner JE. Human facial expressions in response to taste and smell stimulation. Adv Child Dev Behav. 1979;13:257-295.
7. Steiner JE, Glaser D, Hawilo ME, et al. Comparative expression of hedonic impact: affective reactions to taste by human infants and other primates. Neurosci Biobehav Rev. 2001;25:53-74.
8. Rosenstein D, Oster H. Differential facial responses to four basic tastes in newborns. Child Dev. 1988;59:1555-1568.
9. Iwase M, Ouchi Y, Okada H, et al. Neural substrates of human facial expression of pleasant emotion induced by comic films: a PET study. Neuroimage. 2002;17:758-768.
10. Field TM, Woodson R, Greenberg R, et al. Discrimination and imitation of facial expressions by neonates. Science. 1982;218:179-181.
11. LaBarbera JD, Izard CE, Vietze P, et al. Four and six-month-old infants' visual responses to joy, anger, and neutral expressions. Child Dev. 1976;47:535-538.
12. Serrano JM, Iglesias J, Loeches A. Visual discrimination and recognition of facial expressions of anger, fear, and surprise in 4- to 6-month-old infants. Dev Psychobiol. 1992;25:411-425.
13. Soken NH, Pick AD. Infants' perception of dynamic facial expressions: do infants distinguish specific expressions? Child Dev. 1999;70:1275-1282.
14. Field TM, Walden TA. Production and discrimination of facial expressions by preschool children. Child Dev. 1982;53:1299-1311.
15. Ekman P, Keltner D. Universal facial expressions of emotion: an old controversy and new findings. In: Segerstrale U, Molnar P, eds. Nonverbal Communication: Where Nature Meets Culture. Mahwah, NJ: Lawrence Erlbaum Associates; 1997:27-46.
16. Darwin C. The Expression of the Emotions in Man and Animals. Chicago: University of Chicago Press; 1872/1965.
17. Eibl-Eibesfeldt I. Human Ethology. New York: Aldine de Gruyter; 1989.
18. Izard CE. Human Emotion. New York: Plenum Press; 1977.
19. Grammer K, Schiefenhovel W, Schleidt M, et al. Patterns on the face: the eyebrow flash in crosscultural comparison. Ethology. 1988;77:279-299.
20. Sadr J, Jarudi I, Sinha P. The role of eyebrows in face recognition. Perception. 2003;32:285-293.
21. Knappmeyer B, Thorton I, Bulthoff H. The use of facial form during the processing of identity. Vision Res. 2003;43:1921-1936.
22. Harwood N, Hall L, Shinkfield A. Recognition of facial emotional expressions from moving and static displays by individuals with mental retardation. Am J Ment Retard. 1999;104:270-278.
23. Hatfield E, Cacioppo J, Rapson R. Primitive emotional contagion. Review of Personal and Social Psychology. 1992;14:151-177.
24. Wild B, Erb M, Eyb B, et al. Why are smiles contagious? An fMRI study of the interaction between perception of facial affect and facial movements. Psychiatry Research: Neuroimaging. 2003;123:17-36.
25. Frank MG, Ekman P, Friesen WV. Behavioral markers and recognizability of the smile of enjoyment. J Pers Soc Psychol. 1993;64:83-93.
26. Ekman P. Facial expressions of emotion: an old controversy and new findings. Philos Trans R Soc Lond B Biol Sci. 1992;335:63-69.
27. Grammer K, Thornhill R. Human (Homo sapiens) facial attractiveness and sexual selection: the role of symmetry and averageness. J Comp Psychol. 1994;108:233-242.
28. Perret DI, May KA, Yoshikawa S. Facial shape and judgments of female attractiveness. Nature. 1994;368:239-242.
29. Perret DI, Burt DM, Penton-Voak IS, et al. Symmetry and human facial attractiveness. Evol Hum Behav. 1999;20:295-307.
30. Shackelford TK, Larsen RJ. Facial asymmetry as an indicator of psychological, emotional, and physiological distress. J Pers Soc Psychol. 1997;72:456-466.
31. Van Swearingen J, Cohn JF, Turnbull J, et al. Psychological distress: linking impairment with disability in facial neuromuscular disorders. Otolaryngol Head Neck Surg. 1998;118:790.
32. Van Swearingen J, Cohn JF, Bajaj-Luthra A. Specific impairment of smiling increases the severity of depressive symptoms in patients with facial neuromuscular disorders. Aesthetic Plast Surg. 1999;23:416-423.
33. Tos T, Caye-Thomasen P, Stangerup SE, et al. Need for facial reanimation after operations for vestibular schwannoma: patients' perspective. Scand J Plast Reconstr Surg Hand Surg. 2003;37:75-80.
34. Samii M, Matthies C. Management of 1000 vestibular schwannomas (acoustic neuromas): the facial nerve-preservation and restitution of function. Neurosurgery. 1997;40:684-695.
35. Chen JM, Fisch U. The transotic approach in acoustic neuroma surgery. J Otolaryngol. 1993;22:331-336.
36. House WF, Shelton C. Middle fossa approach for acoustic tumor removal. Otolaryngol Clin N Am. 1992;25:347-359.
37. Darrouzet V, Martel J, Enee V, et al. Vestibular schwannoma surgery outcomes: our multidisciplinary experience in 400 cases over 17 years. Laryngoscope. 2004;114:681-688.
38. Magliudo G, D'Amico R, Forino M. Results and complications of facial reanimation following cerebellopontine angle surgery. Eur Arch Otorhinolaryngol. 2001;258:45-48.
39. Samii M. Nerves of the head and neck. In: Omer GE, Spinner M, eds. Management of Peripheral Nerve Problems. Philadelphia: WB Saunders; 1994:507-547.
40. Draf W, Samii M. Intracranial-intratemporal anastomosis of the facial nerve after cerebellopontine angle surgery. In: Graham MD, House WF, eds. Disorders of the Facial Nerve. New York: Raven Press; 1982:441-449.
41. Samii M. Tumors of the internal auditory canal and cerebellopontine angle: acoustic neuroma. In: Samii M, Jannetta P, eds. Surgery of the Skull Base: An Interdisciplinary Approach. Berlin: Springer-Verlag; 1989:377-395.
42. Bento RF, Miniti A. Anastomosis of the intratemporal facial nerve using fibrin tissue adhesive. Ear Nose Throat J. 1993;72:663.
43. Byrne PJ, Hilinski J, Hilger P. Facial nerve repair. Emedicine Web site. October 24, 2003. Available at: http://www.emedicine.com/ent/topic408.htm. Accessed June 1, 2004.
44. Bascom DA, Schaitkin BM, May M, et al. Facial nerve repair: a retrospective review. Facial Plast Surg. 2003;16:309-313.
45. Dott NM. Facial paralysis: restitution by extrapetrous nerve graft. Proc R Soc Med. 1958;51:900-902.
46. Koerte W. Ein fall von nervenpfropfung: des nervus facialis auf den nervus hypoglossus. Dtsch Med Wochenschr. 1903;29:293-295.
47. Streppel M, Popratiloff A, Zero X. Morphological connections between the hypoglossal and facial nerve in the brain stem of the rat. HNO. 2000;48:911-916.
48. May M, Sobol SM, Mester SJ. Hypoglossal-facial interpositional jump graft technique for facial reanimation without tongue atrophy. Otolaryngol Head Neck Surg. 1991;104:818-825.
49. Darrouzet V, Guerin J, Bebear JP. New technique of side-to-end hypoglossal-facial nerve attachment with translocation of the intratemporal facial nerve. J Neurosurg. 1999;90:27-34.
50. Griebie MS, Huff JS. Selective role of partial XI-VII anastomosis in facial reanimation. Laryngoscope. 1998;108:1664-1668.
51. Gilhuis H, Beurskens CH, de Vries J, et al. Contralateral reinnervation of midline muscles in nonidiopathic facial palsy. J Clin Neurophysiol. 2003;20:151-154.
52. Kunihiro T, Higashino K, Kadsaki J. Classic hypoglossal-facial nerve anastomosis after acoustic neuroma resection. A review of 46 cases. J Otorhinolaryngol Relat Spec. 2003;65:1-6.
53. Manni JJ, Beurskens CB, van de Velde C, et al. Successful reanimation of facial paralysis with an indirect anastomosis between hypoglossal nerve and facial nerve, without loss of function of the tongue. Ned Tijdschr Geneeskd. 2001;145:873-877.
54. Guntias-Lichius O. The facial nerve in the presence of a head and neck neoplasm: assessment and outcome after surgical management. Curr Opin Otolarnygol Head Neck Surg. 2004;12:133-141.
55. Myckatyn TM, Mackinnon SE. The surgical management of facial nerve injury. Clin Plast Surg. 2003;30:307-318.
56. May M, Drucker C. Temporalis muscle for facial reanimation: a 13-year experience with 224 procedures. Arch Otolaryngol Head Neck Surg. 1993;119:378-382.
57. Cheney ML, McKenna MJ, Megerian CA, et al. Early temporalis muscle transposition for the management of facial paralysis. Laryngoscope. 1995;105:993-1000.
58. Spector JG. Mimetic surgery for the paralyzed face. Laryngoscope. 1985;95:1495-1522.
59. Clark JM, Shockley W. Management of reanimation of the paralyzed face. In: Papel I, Larrabee WF, Holt CR, et al, eds. Facial Plastic and Reconstructive Surgery. New York: Thieme; 2001:660-688.
60. Freilinger G. A new technique to correct facial paralysis. Plast Reconstr Surg. 1975;56:44-48.
61. Moody FP, Losken A, Bostwick J, et al. Endoscopic frontal branch neurectomy, corrugator myectomy, and brow lift for forehead asymmetry after facial nerve palsy. Plast Reconstr Surg. 2001;108:218-223.
62. Olver JM. Raising the suborbicularis oculi fat (SOOF): its role in chronic facial palsy. Br J Ophthalmol. 2000;84:1401-1406.
63. Horlock N, Sanders R, Harrison DH. The SOOF lift: its role in correcting midfacial and lower facial asymmetry in patients with partial facial palsy. Plast Reconstr Surg. 2002;109:839-849; discussion 850-854.
64. Neely JG, Neufield PS. Defining functional limitation, disability and social limitations in patients with facial paresis: initial pilot questionnaire. Am J Otol. 1996;17:340-342.
65. Esslen E. Electromyographic findings on two types of misdirection of regenerating axons. Electroencephalogr Clin Neurophysiol. 1960;12:738-741.
66. Aldskogius H, Thomander L. Selective reinnervation of somatotopically appropriate muscles after facial nerve transection and regeneration in the neonatal rat. Brain Res. 1986;375:126-134.
67. Brushart TM, Seiler WA. Selective reinnervation of distal motor stumps by peripheral motor axons. Exp Neurol. 1987;97:289-300.
68. Choi D, Raisman G. Somatotopic organization of the facial nucleus is disrupted after lesion and regeneration of the facial nerve: the histological representation of synkinesis. Neurosurgery. 2002;50:355-363.
69. Moran CJ, Neely JG. Patterns of facial nerve synkinesis. Laryngoscope. 1996;106:1491-1496.
70. Choi D, Raisman G. After facial nerve damage, regenerating axons become aberrant throughout the length of the nerve and not only at the site of the lesion: an experimental study. Br J Neurosurg. 2004;18:45-48.
71. Borodic GE, Mills L, Joseph M. Botulinum A toxin for the treatment of adult-onset spasmodic torticollis. Plast Reconstr Surg. 1991;87:285-289.
72. Scott AB, Kennedy RA, Stubbs HA. Botulinum A toxin injection as a treatment for blepharospasm. Arch Ophthalmol. 1985;103:347-350.
73. Ford CN, Bless DM, Lowery JD. Indirect laryngoscopic approach for injection of botulinum toxin in spasmodic dysphonia. Otolaryngol Head Neck Surg. 1990;103:752-758.
74. Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology. 1980;87:1044-1049.
75. Lowe NJ, Yamauchi PS, Lask GP, et al. Efficacy and safety of botulinum toxin type A in the treatment of palmar hyperhidrosis: a double-blind, randomized, placebo-controlled study. Dermatol Surg. 2002;28:822-827.
76. Blitzer A, Brin MF, Keen MS, et al. Botulinum toxin for the treatment of hyperfunctional lines of the face. Arch Otolaryngol Head Neck Surg. 1993;119:1018-1022.
77. Varney SM, Demetroulakos JL, Fletcher MH, et al. Palatal myoclonus: treatment with Clostridium botulinum toxin injection. Otolaryngol Head Neck Surg. 1996;114:317-320.
78. Yoshimura DM, Aminoff MJ, Tami TA, et al. Treatment of hemifacial spasm with botulinum toxin. Muscle Nerve. 1992;15:1045-1049.
79. Biglan AW, May M, Bowers RA. Management of facial spasm with Clostridium botulinum toxin, type A (Oculinium). Arch Otolaryngol Head Neck Surg. 1988;114:1407-1412.
80. Laskawi R. Combination of hypoglossal-facial nerve anastomosis and botulinum toxin injections to optimize mimic rehabilitation after removal of acoustic neuromas. Plast Reconstr Surg. 1997;99:1006-1011.
81. Bikhazi NB, Maas CS. Refinement in the rehabilitation of the paralyzed face using botulinum toxin. Otolaryngol Head Neck Surg. 1997;117:303-307.
82. Biglan AW, Bhupendra CK, Patel CK, et al. Botulinum A toxin. In: May M, Schaitkin BM, eds. The Facial Nerve. 2nd ed. New York: Thieme; 2001:441-465.
83. Carucci JA, Zweibel SM. Botulinum A exotoxin for rejuvenation of the upper third of the face. Facial Plast Surg. 2001;17:11-20.
84. Dressler D, Munchau A, Bhatia KP, et al. Antibody-induced botulinum toxin therapy failure: can it be overcome by increased botulinum toxin doses? Eur Neurol. 2002;47:118-121.
85. Fisch U. Extracranial surgery for facial hyperkinesis. In: May M, ed. The Facial Nerve. 1st ed. New York: Thieme; 1986:535-545.
86. Patel BCK, Anderson RL, May M. Selective myectomy. In: May M, Schaitkin BM, eds. The Facial Nerve. 2nd ed. New York: Thieme; 2001:467-481.
87. Bates AK, Halliday BL, Bailey CS, et al. Surgical management of essential blepharospasm. Br J Ophthalmol. 1991;75:487-490.
88. Frueh BR, Callahan A, Dortzbach RK, et al. The effects of differential section of the VIIth nerve on patients with intractable blepharospasm. Trans Am Acad Ophthalmol Otolaryngol. 1976;81:OP595-OP602.
89. Beurskens CH. Mime therapy: rehabilitation of facial expression [doctoral thesis]. Nijmegen: University of Nijmegen; 2003.
90. Cronin G, Steenerson R. The effectiveness of neuromuscular facial retraining combined with electromyography in facial paralysis rehabilitation. Otolaryngol Head Neck Surg. 2003;128:534-538.
91. Beurskens C, Heymans P. Positive effects of mime therapy on sequelae of facial paralysis: stiffness, lip mobility, and social and physical aspects of facial disability. Otol Neurotol. 2003;24:677-681.
92. Diaz ML, Steele MH, Guerra AB, et al. The role of topically administered FK506 (tacrolimus) at the time of facial nerve repair using entubulation neurorrhaphy in a rabbit model. Ann Plast Surg. 2004;52:407-413.
93. Hefti F. Neurotrophic factor therapy for nervous system degenerative diseases. J Neurobiol. 1986;24:1418-1435.
94. Lindsay RM, Wiegand SJ, Altar CA, et al. Neurotrophic factors: from molecule to man. Trends Neurosci. 1994;17:182-190.
95. Skup MH. BDNF and NT-3 widen the scope of neurotrophin activity: pharmacological implications. Acta Neurobiol Exp (Warsz). 1994;54:81-94.
96. Yuen EC, Mobley WC. Therapeutic potential of neurotrophic factors for neurological disorders. Ann Neurol. 1996;40:346-354.
97. Choi D, Dunn LT. Facial nerve repair and regeneration: an overview of basic principles for neurosurgeons. Acta Neurochir (Wien). 2001;143:107-114.
98. Liu R, Snider WD. Different signaling pathways mediate regenerative versus developmental sensory axon growth. J Neurosci. 2001;21:RC164.
99. Udvadia AJ, Koster RW, Skene JHP. Gap-43 promoter elements in transgenic zebra fish reveal a difference in signals for axon growth during CNS development and regeneration. Development. 2001;128:1175-1182.
100. Jones KJ, Brown TJ, Damaser M. Neuroprotective effects of gonadal steroids on regenerating peripheral motoneurons. Brain Res Brain Res Rev. 2001;37:372-382.
101. Rosales-Cortes M, Peregrina-Sandoval J, Banuelos-Pineda J, et al. Regeneration of the axotomized sciatic nerve in dogs using the tubulization technique with chitosan biomaterial preloaded with progesterone. Rev Neurol. 2003;36:1137-1141.
102. Teare KA, Pearson RG, Shakesheff KM. Alpha-MSH inhibits inflammatory signaling in Schwann cells. Neuroreport. 2004;15:493-498.
103. Streppel M, Azzolin N, Dohm S, et al. Focal application of neutralizing antibodies to soluble neurotrophic factors reduces collateral axonal branching after peripheral nerve lesion. Eur J Neurosci. 2002;15:1327-1342.